106 related articles for article (PubMed ID: 8215470)
1. [Effects of cisplatin, carboplatin, etoposide and human hepatocyte growth factor on the colony formation of four human liver cancer cell lines].
Seshimo K; Hamasaki K; Gohda E; Orita K; Namba M
Gan To Kagaku Ryoho; 1993 Oct; 20(13):1967-72. PubMed ID: 8215470
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
Tyagi AK; Agarwal C; Chan DC; Agarwal R
Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
[TBL] [Abstract][Full Text] [Related]
3. Constitutive production of colony-stimulating factors by human hepatoma cell lines: possible correlation with cell differentiation.
Wang SY; Chen LY; Tsai TF; Su TS; Choo KB; Ho CK
Exp Hematol; 1996 Feb; 24(3):437-44. PubMed ID: 8599973
[TBL] [Abstract][Full Text] [Related]
4. In vitro growth inhibition of cisplatin-resistant human lung cancer cell lines by recombinant human tumor necrosis factor and/or recombinant human interferon-gamma by virtue of collateral sensitivity.
Hong WS; Saijo N; Sasaki Y; Shinkai T; Eguchi K; Sakurai M; Takahashi H; Nakano H; Nakagawa K; Twentyman PR
Jpn J Cancer Res; 1987 Nov; 78(11):1274-80. PubMed ID: 3121562
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways.
Jiang S; Song MJ; Shin EC; Lee MO; Kim SJ; Park JH
Hepatology; 1999 Jan; 29(1):101-10. PubMed ID: 9862856
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Mad transcription factor inhibits proliferation of cultured human hepatocellular carcinoma cells along with tumor formation in immunodeficient animals.
Gagandeep S; Ott M; Nisen PD; DePinho RA; Gupta S
J Gene Med; 2000; 2(2):117-27. PubMed ID: 10809145
[TBL] [Abstract][Full Text] [Related]
7. Human hepatocyte growth factor stimulates the growth of HUH-6 clone 5 human hepatoblastoma cells.
Miyazaki M; Gohda E; Tsuboi S; Tsubouchi H; Daikuhara Y; Namba M; Yamamoto I
Cell Biol Int Rep; 1992 Feb; 16(2):145-54. PubMed ID: 1312905
[TBL] [Abstract][Full Text] [Related]
8. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
[TBL] [Abstract][Full Text] [Related]
9. Etoposide enhances the antitumor effects of cisplatin in gastric cancer cells.
Hotta T; Tanimura H; Yamaue H; Iwahashi M; Tani M; Tsunoda T; Noguchi K; Mizobata S; Arii K; Terasawa H
Anticancer Res; 1997; 17(2A):885-9. PubMed ID: 9137422
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of insulin-like growth factor binding proteins and growth modulation in hepatoma cells by retinoic acid.
Kim DG; Lee DY; Cho BH; You KR; Kim MY; Ahn DS
Hepatology; 1999 Apr; 29(4):1091-8. PubMed ID: 10094952
[TBL] [Abstract][Full Text] [Related]
11. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
Keshelava N; Seeger RC; Groshen S; Reynolds CP
Cancer Res; 1998 Dec; 58(23):5396-405. PubMed ID: 9850071
[TBL] [Abstract][Full Text] [Related]
13. Cycloprodigiosin hydrochloride, a new H(+)/Cl(-) symporter, induces apoptosis in human and rat hepatocellular cancer cell lines in vitro and inhibits the growth of hepatocellular carcinoma xenografts in nude mice.
Yamamoto C; Takemoto H; Kuno K; Yamamoto D; Tsubura A; Kamata K; Hirata H; Yamamoto A; Kano H; Seki T; Inoue K
Hepatology; 1999 Oct; 30(4):894-902. PubMed ID: 10498640
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production.
Poma P; Notarbartolo M; Labbozzetta M; Sanguedolce R; Alaimo A; Carina V; Maurici A; Cusimano A; Cervello M; D'Alessandro N
Int J Oncol; 2006 Apr; 28(4):923-30. PubMed ID: 16525642
[TBL] [Abstract][Full Text] [Related]
15. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
Chen Z; Koeneman KS; Corey DR
Cancer Res; 2003 Sep; 63(18):5917-25. PubMed ID: 14522918
[TBL] [Abstract][Full Text] [Related]
16. Synergistic interaction between platinum-based antitumor agents and demethylcantharidin.
To KK; Ho YP; Au-Yeung SC
Cancer Lett; 2005 Jun; 223(2):227-37. PubMed ID: 15896457
[TBL] [Abstract][Full Text] [Related]
17. [Effects of carboplatin combination with etoposide against leukemia/lymphoma cell lines].
Akutsu M; Suzuki K; Tsunoda S; Kano Y
Gan To Kagaku Ryoho; 1996 Feb; 23(3):297-302. PubMed ID: 8712822
[TBL] [Abstract][Full Text] [Related]
18. Increasing cell membrane potential and GABAergic activity inhibits malignant hepatocyte growth.
Sun D; Gong Y; Kojima H; Wang G; Ravinsky E; Zhang M; Minuk GY
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G12-9. PubMed ID: 12799308
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
Okamura M; Hashimoto K; Shimada J; Sakagami H
Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.
Hand A; Pelin K; Halme M; Ekman A; Mattson M; Vallas M; Mattson K; Linnainmaa K; Husgafvel-Pursiainen K
Anticancer Drugs; 1993 Jun; 4(3):365-8. PubMed ID: 8395259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
